ArticleJournal of pain research2025
Electroacupuncture Prevent and Treat Perioperative Cognitive Impairment in Elderly Patients Undergoing Hip Surgery: A Protocol for a Randomized Controlled Trial.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Electroacupuncture is effective in treating perioperative neurocognitive disorder (PND) and has good application prospects in the prevention and treatment of PND. However, the mechanism of electroacupuncture treatment for PND is comparatively unexplored. Methods/Design: This is a single-center clinical, prospective randomized controlled clinical trial protocol. 180 patients will be randomly divided into the treatment group and the control group in a ratio of 1:1. Both groups of subjects received routine care, while the treatment group will receive electroacupuncture treatment twice a day for 10 days. Acupoints will include Baihui (DU20), Shangxing (DU23), Yintang (EX-HN3), Meichong (BL3), Fengchi (GB20), Cuanzhu (BL2), Laogong (PC8), Hegu (LI4), and Zusanli (ST36). The primary outcome measure is the Mini-mental State Examination (MMSE). And the secondary outcome measures are the Confusion Assessment Method (CAM), Visual Analog Scale (VAS), Pittsburgh Sleep Quality Index (PSQI), Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), neuron-specific enolase (NSE), superoxide dismutase (SOD), central nervous system-specific protein (s100-β) in serum. The outcome measures will be evaluated at baseline, during treatment and 1 week after treatment. What's more, the incidence of non-delirium complications and mortality within 30 days will also be measured. Discussion: Results of this trial are expected to clarify the value of electroacupuncture performed on perioperative cognitive impairment in elderly patients undergoing hip surgery. Ethics: This trial has been approved by the Ethics Committee of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine (No.2024-037). Trial Registration: International Traditional Medicine Clinical Trial Registry, ITMCTR2024000298 (http://itmctr.ccebtcm.org.cn/), registered on 25 August, 2024. The trial will comply with the Declaration of Helsinki.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.